The report includes data on more than 306,000 employed physicians, PhD providers and physician researchers across 915 hospitals, health systems and medical groups nationwide.
Sullivan Cotter attributes the rise in compensation primarily to increased physician productivity. The following 15 specialties saw the largest increases in median total cash compensation in 2024. Only specialties with at least 500 physician respondents are included in the report.
|
Specialty |
Median compensation in 2024 |
Median compensation % change |
wRVU median % change |
|
Hematology and oncology |
$456,632 |
9.7% |
5.4% |
|
Endocrinology and metabolism |
$285,660 |
8% |
6.1% |
|
Radiation oncology |
$550,000 |
7.5% |
5.3% |
|
Pathology – anatomic and clinical |
$424,744 |
6.7% |
7.3% |
|
Geriatrics |
$273,025 |
6.1% |
0.10% |
|
Pulmonology – general |
$375,003 |
6% |
3.8% |
|
Urology |
$530,557 |
5.9% |
3.3% |
|
Urgent care |
$328,596 |
5.8% |
8.3% |
|
Anesthesiology |
$498,973 |
5.6% |
8.5% |
|
Otolaryngology – general |
$491,654 |
5.2% |
3.6% |
|
Pediatrics – hospitalist |
$237,516 |
5.1% |
5.3% |
|
Internal medicine |
$308,288 |
4.8% |
5.7% |
|
Dermatology |
$509,587 |
4.7% |
4% |
|
Nephrology and hypertension |
$350,558 |
4.6% |
1.4% |
|
Physical medicine and rehabilitation |
$312,828 |
4.4% |
6.7% |
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
